LIA
BMRN icon

LS Investment Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

LS Investment Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-258
Closed -$22K – 1648
2020
Q1 		$22K Sell
258
-832
-76% -$71.7K ﹤0.01% 1331
2019
Q4 		$92K Hold
1,090
– – 0.01% 1134
2019
Q3 		$73K Hold
1,090
– – ﹤0.01% 1174
2019
Q2 		$93K Hold
1,090
– – 0.01% 1100
2019
Q1 		$97K Hold
1,090
– – 0.01% 1099
2018
Q4 		$93K Sell
1,090
-361
-25% -$34.3K 0.01% 1086
2018
Q3 		$141K Hold
1,451
– – 0.01% 1002
2018
Q2 		$137K Hold
1,451
– – 0.01% 1032
2018
Q1 		$118K Hold
1,451
– – 0.01% 1065
2017
Q4 		$129K Hold
1,451
– – 0.01% 1072
2017
Q3 		$135K Hold
1,451
– – 0.01% 1068
2017
Q2 		$132K Hold
1,451
– – 0.01% 1046
2017
Q1 		$127K Hold
1,451
– – 0.01% 1039
2016
Q4 		$120K Hold
1,451
– – 0.01% 983
2016
Q3 		$134K Sell
1,451
-495
-25% -$46.6K 0.01% 915
2016
Q2 		$151K Buy
1,946
+231
+13% +$19.6K 0.01% 868
2016
Q1 		$141K Buy
1,715
+72
+4% +$5.86K 0.01% 744
2015
Q4 		$172K Buy
1,643
+179
+12% +$18.7K 0.01% 673
2015
Q3 		$154K Hold
1,464
– – 0.01% 691
2015
Q2 		$200K Sell
1,464
-497
-25% -$61.6K 0.01% 628
2015
Q1 		$244K Sell
1,961
-329
-14% -$34.9K 0.02% 538
2014
Q4 		$207K Hold
2,290
– – 0.02% 575
2014
Q3 		$165K Hold
2,290
– – 0.01% 596
2014
Q2 		$142K Sell
2,290
-90
-4% -$5.44K 0.01% 621
2014
Q1 		$162K Hold
2,380
– – 0.01% 601
2013
Q4 		$167K Buy
+2,380
New +$162K 0.02% 586

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

LS Investment Advisors's BMRN Position: Q2 2020 in Review

LS Investment Advisors sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2020, closing a stake of 258 shares — an estimated $22K sold.

LS Investment Advisors first reported a position in BMRN in Q4 2013 and held it in 26 quarters. The position peaked at $244K in Q1 2015. 527 funds tracked by Wall St. Rank hold BMRN as of Q2 2020.

  • LS Investment Advisors reported no remaining BioMarin Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • LS Investment Advisors sold 258 BioMarin Pharmaceuticals shares in Q2 2020, an estimated $22K.
  • LS Investment Advisors first reported a position in BioMarin Pharmaceuticals in Q4 2013 and held it in 26 quarters.
  • LS Investment Advisors's BioMarin Pharmaceuticals position peaked at $244K in Q1 2015.
  • 527 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2020.

Based on LS Investment Advisors's 13F filing for Q2 2020, filed 10 Aug 2020.